What does DOKTER LIESBET GEUSENS do?

DOKTER LIESBET GEUSENS is a specialist medical practice in Zandhoven. Private Limited, started on 30 August 2007, 1 establishment.

What is the address of DOKTER LIESBET GEUSENS?

The registered office of DOKTER LIESBET GEUSENS is located at Liersebaan 41, 2240 Zandhoven.

Is DOKTER LIESBET GEUSENS still active?

Yes. According to the CBE (16 September 2026) DOKTER LIESBET GEUSENS is active, legal situation “Normale toestand”, started on 30 August 2007.

Is DOKTER LIESBET GEUSENS registered on Peppol?

Yes, DOKTER LIESBET GEUSENS is registered on the Peppol network with ID 0208:0891727928.

What is the enterprise number of DOKTER LIESBET GEUSENS?

The enterprise number of DOKTER LIESBET GEUSENS is BE0891727928.

When was DOKTER LIESBET GEUSENS founded?

DOKTER LIESBET GEUSENS was founded on 30 August 2007.

Who are the directors of DOKTER LIESBET GEUSENS?

According to the 2025 annual accounts, the directors of DOKTER LIESBET GEUSENS are: Liesbet GEUSENS.

Is DOKTER LIESBET GEUSENS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 August 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOKTER LIESBET GEUSENS make in 2025?

DOKTER LIESBET GEUSENS posted a profit after taxes of € 94,236 in financial year 2025.

What is the revenue of DOKTER LIESBET GEUSENS?

As a small company, DOKTER LIESBET GEUSENS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 149,893.

DOKTER LIESBET GEUSENS (Private Limited) - Zandhoven

Dossier DOKTER LIESBET GEUSENS, printed on 16 September 2026 from databakkes.be/en/0891727928/dokter-liesbet-geusens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTER LIESBET GEUSENS from Zandhoven, company number BE0891727928, closed financial year 2025 with a result of € 94,236 after tax. For that financial year DOKTER LIESBET GEUSENS recorded a gross margin of € 149,893 and equity of € 281,503. Compared with financial year 2024, the result moved from € 84,275 to € 94,236. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 22, 2026.

What it is worth Healthy

€ 281,503

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 94,236

▲ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 186,854

▲ 23% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 98,410 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Wage cost

€ 3,187

▲ 152% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 8,684

▼ 2% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 435

▼ 92% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 19,516

▲ 57% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 80,582 Gross margin 2022: € 80,582 First fiscal year in the series	€ 110,819 Gross margin 2023: € 110,819 ▲ 38% vs 2022 (€ 80,582) Favourable step	€ 139,082 Gross margin 2024: € 139,082 ▲ 26% vs 2023 (€ 110,819) Favourable step	€ 149,893 Gross margin 2025: € 149,893 ▲ 8% vs 2024 (€ 139,082) Favourable step	▲ 8%
Profit after taxes	€ 41,660 Profit after taxes 2022: € 41,660 First fiscal year in the series	€ 58,897 Profit after taxes 2023: € 58,897 ▲ 41% vs 2022 (€ 41,660) Favourable step	€ 84,275 Profit after taxes 2024: € 84,275 ▲ 43% vs 2023 (€ 58,897) Favourable step	€ 94,236 Profit after taxes 2025: € 94,236 ▲ 12% vs 2024 (€ 84,275) Favourable step	▲ 12%
Equity	€ 209,581 Equity 2022: € 209,581 First fiscal year in the series	€ 243,576 Equity 2023: € 243,576 ▲ 16% vs 2022 (€ 209,581) Favourable step	€ 285,677 Equity 2024: € 285,677 ▲ 17% vs 2023 (€ 243,576) Favourable step	€ 281,503 Equity 2025: € 281,503 ▼ 1% vs 2024 (€ 285,677) Unfavourable step	▼ 1%
Total debts	€ 47,712 Total debts 2022: € 47,712 First fiscal year in the series	€ 39,072 Total debts 2023: € 39,072 ▼ 18% vs 2022 (€ 47,712) Favourable step	€ 60,014 Total debts 2024: € 60,014 ▲ 54% vs 2023 (€ 39,072) Unfavourable step	€ 118,362 Total debts 2025: € 118,362 ▲ 97% vs 2024 (€ 60,014) Unfavourable step	▲ 97%
Cash	€ 171,370 Cash 2022: € 171,370 First fiscal year in the series	€ 151,707 Cash 2023: € 151,707 ▼ 11% vs 2022 (€ 171,370) Unfavourable step	€ 151,929 Cash 2024: € 151,929 Unchanged (€ 151,707) Favourable step	€ 186,854 Cash 2025: € 186,854 ▲ 23% vs 2024 (€ 151,929) Favourable step	▲ 23%
Land & buildings	€ 39,052 Land & buildings 2022: € 39,052 First fiscal year in the series	€ 59,350 Land & buildings 2023: € 59,350 ▲ 52% vs 2022 (€ 39,052) Unchanged	€ 50,505 Land & buildings 2024: € 50,505 ▼ 15% vs 2023 (€ 59,350) Unchanged	€ 41,660 Land & buildings 2025: € 41,660 ▼ 18% vs 2024 (€ 50,505) Unchanged	▼ 18%
Retained profit	€ 208,581 Retained profit 2022: € 208,581 First fiscal year in the series	€ 242,576 Retained profit 2023: € 242,576 ▲ 16% vs 2022 (€ 208,581) Favourable step	€ 284,677 Retained profit 2024: € 284,677 ▲ 17% vs 2023 (€ 242,576) Favourable step	€ 280,503 Retained profit 2025: € 280,503 ▼ 1% vs 2024 (€ 284,677) Unfavourable step	▼ 1%
Dividend	€ 2,060 Dividend 2022: € 2,060 First fiscal year in the series	€ 24,902 Dividend 2023: € 24,902 ▲ € 22,842 vs 2022 (€ 2,060) Unchanged	€ 42,174 Dividend 2024: € 42,174 ▲ 69% vs 2023 (€ 24,902) Unchanged	€ 98,410 Dividend 2025: € 98,410 ▲ 133% vs 2024 (€ 42,174) Unchanged	▲ 133%
Bank debt	€ 7,694 Bank debt 2022: € 7,694 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 7,694) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 257,293 Balance sheet total 2022: € 257,293 First fiscal year in the series	€ 282,648 Balance sheet total 2023: € 282,648 ▲ 10% vs 2022 (€ 257,293) Unchanged	€ 345,691 Balance sheet total 2024: € 345,691 ▲ 22% vs 2023 (€ 282,648) Unchanged	€ 399,865 Balance sheet total 2025: € 399,865 ▲ 16% vs 2024 (€ 345,691) Unchanged	▲ 16%

Key figures of DOKTER LIESBET GEUSENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTER LIESBET GEUSENS?

What happened at DOKTER LIESBET GEUSENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 22, 2026 New annual accounts for financial year 2025: profit of € 94,236 (▲ 12% vs 2024). Source: NBB ↗
2009 Liesbet GEUSENS became a director. NBB
Sep 7, 2007 New establishment in Zandhoven. KBO
Aug 30, 2007 Start of the company according to the CBE. KBO

In short

From € 41,660 profit in 2022 to € 94,236 profit in 2025.

Paid € 110,069 in corporate taxes since 2022.

Best year ever: 2025, with € 94,236 profit.

Paid out € 167,546 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER LIESBET GEUSENS? We notify you, reason included.

Follow DOKTER LIESBET GEUSENS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Liesbet GEUSENS

DOKTER LIESBET GEUSENS

Behind DOKTER LIESBET GEUSENS is Liesbet GEUSENS.

See the full network in the app

Directors

According to the 2025 annual accounts

Liesbet GEUSENS

Director

since 2009

Establishments

Establishment units

Physical locations of this company

Registered office

Liersebaan 41

2240 Zandhoven

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

DERMATOLOGIE ZANDHOVEN

DERMATOLOGIE VSE

€ 135,947 gross margin · 2025

DR. ANN DE SWERDT

€ 107,039 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0891.727.928
VAT number: BE 0891.727.928
Registered office: Liersebaan 41, 2240 Zandhoven
Names & denominations: DOKTER LIESBET GEUSENS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 30 August 2007
Peppol: Active · Active since 9 Oct 2024
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗